論文情報Publications

新着論文

  • "Continuous extracorporeal treatments in a dialysis patient with COVID-19." Nihei Y et al. CEN Case Rep (Oct 4, 2020 online)

    PubMed
  • "Adjunctive therapies for early withdrawal from extracorporeal membrane oxygenation." Ogawa H et al. J Cardiac Surg (Sep 29, 2020 online)

    PubMed
  • "Effectiveness of polymyxin B-immobilized hemoperfusion against sepsis and septic shock: A systematic review and meta-analysis." Li X et al. J Crit Care (Sep 18, 2020 online)

    PubMed
  • "Cytokine Adsorption to Polymyxin B-Immobilized Fiber: An in vitro Study." Utsunomiya Y et al. Blood Purif (Sep 7, 2020 online)

    PubMed
  • "Successful Recovery from COVID-19-associated Acute Respiratory Failure with Polymyxin B-immobilized Fiber Column-direct Hemoperfusion." Kusaba Y et al. Intern Med (2020) 59:2405-08

    PubMed
  • "Treatment of Pyonephritis Complicated by Septic Shock Using Extracorporeal Device Polymyxin B-Hemoperfusion." Amoruso G et al. Blood Purif (2020) 49:627-30

    PubMed
  • "Intensive care management of a patient with necrotizing fasciitis due to non-O1/O139 Vibrio cholerae after traveling to Taiwan: a case report." Tsuruta K et al. BMC Infectious Diseases (2020) 20:618

    PubMed
  • "Severe Sepsis Caused by Bacteria That Entered via the Intestinal Tract: A Case of Crohn's Disease in a Child." Satoh K et al. Cureus (2020) 12:e9822

    PubMed
  • "A case of successful treatment of severe COVID-19 pneumonia with favipiravir and tocilizumab in post–kidney transplant recipient." Thammathiwat et al. Transpl Infect Dis (2020) 00:e13388

    PubMed
  • "Initial Experience of Using Polymyxin B Hemoperfusion in Abdominal Septic Shock: Things to Consider for Better Outcome." Park YJ et al. J Acute Care Surg (2020) 10:13-7

  • "Effects of endotoxin adsorber hemoperfusion on sublingual microcirculation in patients with septic shock: a randomized controlled trial." Chen SH et al. (2020) Ann Intensive Care 10:80

    PubMed
  • "Lactate predicts the 28-day survival rate in patients with septic shock treated with the combination of PMX-DHP and rTM." Yamato M et al. Ther Apher Dial (2020) June 10

    PubMed
  • "Beneficial Effect Modification on Survival Outcome of Sepsis Between ART-123 and Polymyxin B‑immobilised Haemoperfusion: A Nationwide Japanese Registry Study" Mochizuki K et al. Ann Intensive Care (2020) 10:57

    PubMed
  • "Septicemia, Necrotizing Fasciitis, and Peritonitis Due to Vibrio Vulnificus Treated With Early Use of Polymyxin B Hemoperfusion in a Patient Undergoing CAPD: A Case Report." Kim JY et al. BMC Nephrol (2020) 21:127

    PubMed
  • "Importance of Endotoxin Clearance in Endotoxemic Septic Shock: An Analysis From the Evaluating Use of PolymyxinB Hemoperfusion in a Randomized Controlled Trial of Adults Treated for Endotoxemic Septic Shock (EUPHRATES) Trial." Rachoin JS et al. Crit Care Expl (2020) 2:e0083

    PubMed
  • "Successful treatment of direct hemoperfusion with polymyxin B immobilized fiber for septic shock and severe acute kidney injury due to ceftriaxone-resistant Escherichia coli: a case report with literature review." Shima H et al. Renal Replacement Ther (2020) 6:16

  • "Identifying Septic Shock Populations Benefitting from Polymyxin B Hemoperfusion: A Prospective Cohort Study Incorporating a Restricted Cubic Spline Regression Model." Nakata H et al. Shock (2020) Mar 17

    PubMed
  • "Clinical effects of polymyxin B-immobilized fiber column direct hemoperfusion for severe bacterial meningitis: A series of 10 cases." Suzuki Y et al. Clin Case Rep (2020) 8:823-32

    PubMed
  • "Could There Be a Biologically Plausible Niche for Polymyxin B-Immobilized Fiber Column Direct Hemoperfusion Treatment in Early Onset Neonatal Septic Shock?" Aldewereld Z et al. Pediatr Crit Care Med (2020) 21:202-3

    PubMed
  • "Sequential Extracorporeal Therapy Collaborative Device and Timely Support for Endotoxic, Septic, and Cardiac Shock: A Case Report."De Rosa S et al. Blood Purif (2020) 49:502-98

    PubMed
  • "Polymyxin B hemoperfusion as a feasible therapy after source control in abdominal septic shock."Kim JJ et al. World J Gastrointest Surg (2019) 11:422-32 

    PubMed
  • "Effect of polymyxin B hemoperfusion on the outcome of patients with sepsis and septic shock."Lin WT et al. J Infect (2020) 80:350-371

    PubMed
  • "Removal of Circulating Neutrophil Extracellular Trap Components with an Immobilized Polymyxin B Filter: A Preliminary Study." Gocho T et al. Shock (2020) 54:44-9

    PubMed
  • "Clinical Effects and Outcomes After Polymyxin B–Immobilized Fiber Column Direct Hemoperfusion Treatment for Septic Shock in Preterm Neonates." Nishizaki N et al. Pediatr Crit Care Med (2020) 21:156-63

    PubMed
  • "Endotoxin removal by polymyxin B: is it a question of dose or duration or both?"Honore PM et al. (2019) Critical Care 23:297

    PubMed
  • "The Golden Hour of Polymyxin B Hemoperfusion in Endotoxic Shock: The Basis for Sequential Extracorporeal Therapy in Sepsis (SETS)." De Rosa S et al. Artif Organs (2020) 44:184-6

    PubMed
  • " Use of Direct Hemoperfusion with Polymyxin B-Immobilized Fiber for the Treatment of Septic Shock Complicated with Lemierre Syndrome Caused by Fusobacterium necrophorum." Kodama Y et al. Case Rep Crit Care (2019)
    2019:5740503

    PubMed
  • "Impact of timing of polymyxin B-immobilized fiber column direct hemoperfusion on outcome in patients with septic shock: a single-center observational study." Tanaka T et al. Acute Med Surg (2020) 7:e446.

    PubMed
  • "Double Extracorporeal Blood Purification in refractory pediatric septic shock." Rossetti E R et al. Pediatric Anesthesia (2019) 29:966-7

    PubMed
  • "Blood Purification and Mortality in Sepsis and Septic Shock: A Systematic Review and Meta-analysis of Randomized Trials." Putzu A et al. Anesthesiology (2019) 131:580-93

    PubMed
  • "Refractory Septic Shock due to Acute Cholangitis Successfully Treated with Polymyxin B Hemoperfusion: A Case Report." Ohtsuka Y et al. J Gastrointest Dig Syst (2019) 9:1000597

  • "Effects of prolonged direct hemoperfusion using a polymyxin B immobilized fiber cartridge on interleukin-6 concentration in patients with septic shock: a prospective exploratory trial." Miyamoto K et al. Renal Replacement Ther (2019) 5:20

  • "The wind changed direction and the big river still flows: from EUPHRATES to TIGRIS." J Intensive Care (2019) 7:31

    PubMed
  • "The Role of Endotoxin in Septic Shock." Hurley JC et al. JAMA (2019) 321:902-3

    PubMed

    "The Role of Endotoxin in Septic Shock - Reply." Marshal JC et al. JAMA (2019) 321:903

    PubMed
  • "The effect of direct hemoperfusion with polymyxin B immobilized cartridge on meropenem in critically ill patients requiring renal support." Singhan W et al. J Crit Care (2019) 51:71-6

    PubMed
  • "A Successful Application of Adult Polymyxin B-Immobilized Fiber Column Hemoperfusion to a Neonate with Septic Shock." Kim YA et al. Acute Crit Care (2018) Nov 9

  • "LPS Removal Reduces CD80-Mediated Albuminuria in Critically Ill Patients with Gram-negative Sepsis." Giuseppe SN et al. Am J Physiol Renal Physiol (2019) 316:F723-31

    PubMed
  • "Impact of hemoperfusion with polymyxin B added to hemofiltration in patients with  endotoxic shock: a case–control study." Navas A et al. Ann Intensive Care (2018) 8:121

    PubMed
  • "Treatment with a polymyxin B filter to capture endotoxin in sepsis patients: is there a signal for therapeutic efficacy." Pickkers P et al. Intensive Care Med (2019) 45:282-3

    PubMed
  • "Polymyxin B hemoperfusion in endotoxemic septic shock patients without extreme endotoxemia: a post hoc analysis of the EUPHRATES trial." Klein DJ et al. Intensive Care Med (2018) 44:2205-12

    PubMed

主要論文

  • "Effects of endotoxin adsorber hemoperfusion on sublingual microcirculation in patients with septic shock: a randomized controlled trial." Chen SH et al. (2020) Ann Intensive Care 10:80

    PubMed
  • "Polymyxin B hemoperfusion in endotoxemic septic shock patients without extreme endotoxemia: a post hoc analysis of the EUPHRATES trial." Klein DJ et al. Intensive Care Med (2018) Nov. 23

    PubMed
  • "The effect of polymyxin B hemoperfusion on modulation of human leukocyte antigen DR in severe sepsis patients." Srisawat N et al. Crit Care (2018) 22:279

    PubMed
  • "Effect of Targeted Polymyxin B Hemoperfusion on 28-Day Mortality in Patients With Septic Shock and Elevated Endotoxin Level: The EUPHRATES Randomized Clinical Trial.." Dellinger RP et al. JAMA (2018) 320:1455-63

    PubMed
  • "Polymyxin B-immobilized hemoperfusion and mortality in critically ill adult patients with sepsis/septic shock: a systematic review with meta-analysis and trial sequential analysis." Fujii T et al. Intensive Care Med (2018) 44:167-78

    PubMed
  • "Potential survival benefit of polymyxin B hemoperfusion in patients with septic shock: a propensity-matched cohort study." Nakamura Y et al. Crit Care (2017) 21:134

    PubMed
  • "Effects of Polymyxin B Hemoperfusion on Mortality in Patients With Severe Sepsis and Septic Shock: A Systemic Review, Meta-Analysis Update, and Disease Severity Subgroup Meta-Analysis." Chang T et al. Crit Care Med (2017) 45:e858-e864

    PubMed
  • "Polymyxin B Hemoperfusion for Sepsis and Septic Shock: A Systematic Review and Meta-Analysis. "Terayama T et al. Surg Infect (2017) 18:225-33

    PubMed
  • "Polymyxin-B hemoperfusion in septic patients: analysis of a multicenter registry." Cutuli SL et al. Ann Intensive Care (2016) 6:77

    PubMed
  • "Potential Survival Benefit of Polymyxin B Hemoperfusion in Septic Shock Patients on Continuous Renal Replacement Therapy: A Propensity-Matched Analysis." Iwagami M et al. Blood Purif (2016) 42:9-17

    PubMed
  • "Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis: a multicenter randomized control trial." Payen D et al. Intensive Care Med (2015) 41:975-84

    PubMed
  • "Rescue therapy with Polymyxin B hemoperfusion in high dose vasopressor therapy Refractory Septic Shock." Monti G et al. Minerva Anestesiol (2015) 81:516-2

    PubMed
  • "Endotoxin adsorption using polymyxin B immobilized fiber cartridges in severe sepsis patients following cardiac surgery." Yaroustovsky M et al. Int J Artif Organs (2014) 37:299-307

    PubMed
  • "Postoperative Polymyxin B Hemoperfusion and Mortality in Patients With Abdominal Septic Shock: A Propensity-Matched Analysis." Iwagami M et al. Crit Care Med (2013) 42:1187-93

    PubMed
  • "Blood Purification and Mortality in Sepsis:A Meta-analysis of Randomized Trials." Zhou F et al. Crit Care Med (2013) 41:2209-2220

    PubMed
  • "Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial." Cruz DN et al. JAMA (2009) 301:2445-52

    PubMed
  • "Polymyxin-B hemoperfusion inactivates circulating proapoptotic factors." Cantaluppi V et al. Intensive Care Med (2008) 34:1638-45

    PubMed
  • "Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic review." Cruz DN et al. Crit Care (2007) 11:R47

    PubMed
  • "A pilot-controlled study of a polymyxin B-immobilized hemoperfusion cartridge in patients with severe sepsis secondary to intra-abdominal Infection." Vincent JL et al. Shock (2005) 23:400-5

    PubMed

総説

  • "Evidence and Perspectives on the Use of Polymyxin B-Immobilized Fiber Column Hemoperfusion among Critically Ill Patients." Yamashita C et al. Contrib Nephrol (2018) 196:215-22

    PubMed
  • "History and current status of polymyxin B-immobilized fiber column for treatment of severe sepsis and septic shock" Shimizu T et al. Ann Gastroenterol Surg (2017) 2017:1–9

    PubMed
  • "Polymyxin B hemoperfusion: a mechanistic perspective." Ronco C et al. Crit Care (2014) 18:309

    PubMed
  • "Immunomodulation in Sepsis: The Role of Endotoxin Removal by Polymyxin B-Immobilized Cartridge." Esteban E et al. Mediators Inflamm (2013) 2013:507539

    PubMed
  • 「海外におけるポリミキシンB固定化繊維カラムの臨床応用の現状,および研究の今後の進むべき方向」小路久敬 日本集中治療医学会誌(2012)3:109-16
  • 「血中エンドトキシン除去カラム(PMX)の有用性と意義の確立に向けた多角的アプローチ」小路久敬 日本アフェレシス学会雑誌(2012)31:109-17

論文リスト